VEGFA and lymphedema: The remaining cytokines assayed (TNF-β; RANTES; interleukins 1a and b, 2–7, 10, and 23; interleukin 12 p40 and p70; interferon-γ; granulocyte and granulocyte-macrophage colony-stimulating factors; IP10; and VEGF-A) showed no significant differences between treated and untreated lymphedema cohorts.